Answers are grounded in this paper and cite their sources.
Intravenous immunoglobulin is used as a replacement therapy in primary immunodeficiency diseases as well as an immunomodulatory agent in a variety of autoimmune and inflammatory disorders. The mechanisms of intravenous immunoglobulin action are complex and, for some disorders, not well understood. This paper reviews the recent literature and discusses approved, new, and controversial indications for intravenous immunoglobulin therapy, with special emphasis on its mechanism of action.
No takes yet. Share an insight, caveat, or question.
Nowak‐Węgrzyn et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: